CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jaskowski, T. D.
Right arrow Articles by Hill, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jaskowski, T. D.
Right arrow Articles by Hill, H. R.
Clinical and Vaccine Immunology, February 2006, p. 277-280, Vol. 13, No. 2
1071-412X/06/$08.00+0     doi:10.1128/CVI.13.2.277-280.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Detection of {kappa} and {lambda} Light Chain Monoclonal Proteins in Human Serum: Automated Immunoassay versus Immunofixation Electrophoresis

Troy D. Jaskowski,1* Christine M. Litwin,1,2 and Harry R. Hill1,2,3

Associated Regional and University Pathologists Institute for Clinical and Experimental Pathology,1 Departments of Pathology,2 Pediatrics and Medicine, University of Utah School of Medicine, Salt Lake City, Utah 841083

Received 28 September 2005/ Returned for modification 14 November 2005/ Accepted 7 December 2005

Recently, turbidimetric immunoassays for detecting and quantifying {kappa} and {lambda} free light chains (FLC) have become available and are promoted as being more sensitive than immunofixation electrophoresis (IFE) in detecting FLC monoclonal proteins. In this study, we assessed the ability of these turbidimetric assays to detect serum monoclonal proteins involving both free and heavy-chain-bound {kappa} and {lambda} light chains compared to standard immunofixation electrophoresis. Sera demonstrating a restricted band of protein migration (other than a definite M spike) by serum protein electrophoresis (SPE), which may represent early monoclonal proteins, were also examined. When compared to IFE, percent agreement, sensitivity, and specificity for the {kappa}-FLC and {lambda}-FLC were 94.6, 72.9, and 99.5% and 98.5, 91.4, and 99.7%, respectively, in detecting monoclonal proteins involving free and heavy-chain-bound light chains. The majority of sera (73.7%) demonstrating a restricted band of protein migration on SPE demonstrated abnormal IFE patterns suggestive of multiple myeloma or monoclonal gammopathy of unknown significance, but gave normal {kappa}/{lambda} FLC ratios using the turbidimetric immunoassays. In conclusion, the {kappa} and {lambda} FLC assays are significantly less sensitive (72.9 to 91.4%) than IFE, but specific in detecting serum monoclonal proteins. Moreover, the {kappa}/{lambda} ratio has little value in routine screening since the majority of sera with abnormal IFE patterns had normal {kappa}/{lambda} FLC ratios.


* Corresponding author. Mailing address: Associated Regional and University Pathologists Institute for Clinical and Experimental Pathology, 500 Chipeta Way, Salt Lake City, UT 84108. Phone: (801) 583-2787, ext. 2817. Fax: (801) 584-5109. E-mail: jaskowtd{at}aruplab.com.


Clinical and Vaccine Immunology, February 2006, p. 277-280, Vol. 13, No. 2
1071-412X/06/$08.00+0     doi:10.1128/CVI.13.2.277-280.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.